The board of directors of The United Laboratories International Holdings Limited announced that, based on the unaudited consolidated management accounts of the Company and its subsidiaries (the "Group") for the year ended 31 December 2023 prepared in accordance with Hong Kong Financial Reporting Standards, the Group is expected to record a net profit of approximately RMB 2,600,000,000 for the year ended 31 December 2023, while the net profit for the year ended 31 December 2022 is approximately RMB 1,581,000,000.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 HKD | -2.43% | -0.96% | +31.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.95% | 2.2B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 3933 Stock
- News The United Laboratories International Holdings Limited
- The United Laboratories International Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023